{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cyclodextrin", "In silico", "Main protease", "Medicinal plants", "SARS-CoV-2", "Spike receptor"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34189252", "DateRevised": {"Year": "2021", "Month": "07", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "24"}], "Language": ["eng"], "ELocationID": ["10.1016/j.imu.2021.100645"], "Journal": {"ISSN": "2352-9148", "JournalIssue": {"Volume": "25", "PubDate": {"Year": "2021"}}, "Title": "Informatics in medicine unlocked", "ISOAbbreviation": "Inform Med Unlocked"}, "ArticleTitle": "In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (M<sup>pro</sup>) and spike (S) receptor.", "Pagination": {"StartPage": "100645", "MedlinePgn": "100645"}, "Abstract": {"AbstractText": ["The current outbreak of novel coronavirus disease (COVID-19) causes an alarming number of deaths in 221 countries around the world. Nowadays, there is no specific and effective drug regimen for curing COVID-19. Since the COVID-19 pandemic, several medicinal plants with promising results in the previous SARS-CoV could be used to treat SARS-CoV-2 infected patients. This work assesses proven medicinal plants as potential inhibitors against SARS-CoV-2 main protease (Mpro) and spike (S) receptors by employing <i>in silico</i> methods. Molecular docking studies and 3D structure-based pharmacophore modeling were performed to identify the molecular interactions of potential active molecules with the Mpro and (S) receptor of SARS-CoV-2. The drug-likeness and ADME properties were also predicted to support the drug-like nature of the selected active molecules. The results indicated that the most favorable ligand was Terrestriamide with (\u0394G: \u25008.70\u00a0kcal/mol; Ki: 0.417\u00a0\u03bcM) and (\u0394G: \u25007.02\u00a0kcal/mol; Ki: 7.21\u00a0\u03bcM) for Mpro and (S) receptor, respectively. Terrestriamide is also supported with a high drug-likeness value and appropriate ADME profile. Furthermore, to improve drug delivery, the cyclodextrin inclusion complex was calculated based on semi-empirical quantum mechanical methods. Terrestriamide/\u03b3-cyclodextrin is the most favorable pathway of inclusion complex formation and could be used to treat COVID-19."], "CopyrightInformation": "\u00a9 2021 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Warsaw, Poland."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Indonesia."}], "LastName": "Dermawan", "ForeName": "Doni", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Environmental Protection and Management, Jagiellonian University, Krakow, Poland."}], "LastName": "Prabowo", "ForeName": "Bagas Adji", "Initials": "BA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Food Technology and Human Nutrition, University of Agriculture in Krakow, Krakow, Poland."}], "LastName": "Rakhmadina", "ForeName": "Casilda Aulia", "Initials": "CA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Inform Med Unlocked", "NlmUniqueID": "101718051", "ISSNLinking": "2352-9148"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506.", "ArticleIdList": ["PMC7159299", "31986264"]}, {"Citation": "Adil M.T., Rahman R., Whitelaw D., Jain V., Al-Taan O., Rashid F., Munasinghe A., Jambulingam P. SARS-CoV-2 and the pandemic of COVID-19, Postgrad. Med J. 2021;97:110\u2013116. doi: 10.1136/postgradmedj-2020-138386.", "ArticleIdList": ["10.1136/postgradmedj-2020-138386", "PMC10016996", "32788312"]}, {"Citation": "WHO . 2020. Weekly operational update on COVID-19, world heal. Organ; pp. 1\u201310.https://www.who.int/publications/m/item/weekly-operational-update-on-covid-19---22-february-2021"}, {"Citation": "Machhi J., Herskovitz J., Senan A.M., Dutta D., Nath B., Oleynikov M.D., Blomberg W.R., Meigs D.D., Hasan M., Patel M., Kline P., Chang R.C.C., Chang L., Gendelman H.E., Kevadiya B.D. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15:359\u2013386. doi: 10.1007/s11481-020-09944-5.", "ArticleIdList": ["10.1007/s11481-020-09944-5", "PMC7373339", "32696264"]}, {"Citation": "Woo P.C.Y., Huang Y., Lau S.K.P., Yuen K.Y. Coronavirus genomics and bioinformatics analysis. Viruses. 2010;2:1805\u20131820. doi: 10.3390/v2081803.", "ArticleIdList": ["10.3390/v2081803", "PMC3185738", "21994708"]}, {"Citation": "Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., Penzar D., Perlman S., Poon L.L.M., Samborskiy D.V., Sidorov I.A., Sola I., Ziebuhr J. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5:536\u2013544. doi: 10.1038/s41564-020-0695-z.", "ArticleIdList": ["10.1038/s41564-020-0695-z", "PMC7095448", "32123347"]}, {"Citation": "Chen Y., Liu Q., Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418\u2013423. doi: 10.1002/jmv.25681.", "ArticleIdList": ["10.1002/jmv.25681", "PMC7167049", "31967327"]}, {"Citation": "Ullrich S., Nitsche C. 2020. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect , the company \u2019 s public news and information."}, {"Citation": "Saxena A. Drug targets for COVID-19 therapeutics: ongoing global efforts. J Biosci. 2020;45 doi: 10.1007/s12038-020-00067-w.", "ArticleIdList": ["10.1007/s12038-020-00067-w", "PMC7323606", "32661214"]}, {"Citation": "Masters P.S. The molecular biology of coronaviruses. Adv Virus Res. 2006;65:193\u2013292. doi: 10.1016/S0065-3527(06)66005-3.", "ArticleIdList": ["10.1016/S0065-3527(06)66005-3", "PMC7112330", "16877062"]}, {"Citation": "Ziebuhr J., Snijder E.J., Gorbalenya A.E. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol. 2000;81:853\u2013879. doi: 10.1099/0022-1317-81-4-853.", "ArticleIdList": ["10.1099/0022-1317-81-4-853", "10725411"]}, {"Citation": "Khailany R.A., Safdar M., Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Reports. 2020;19 doi: 10.1016/j.genrep.2020.100682.", "ArticleIdList": ["10.1016/j.genrep.2020.100682", "PMC7161481", "32300673"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., M\u00fcller M.A., Drosten C., P\u00f6hlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u2013280.e8.", "ArticleIdList": ["PMC7102627", "32142651"]}, {"Citation": "Du L., He Y., Zhou Y., Liu S., Zheng B.J., Jiang S. The spike protein of SARS-CoV - a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7:226\u2013236. doi: 10.1038/nrmicro2090.", "ArticleIdList": ["10.1038/nrmicro2090", "PMC2750777", "19198616"]}, {"Citation": "Pillaiyar T., Meenakshisundaram S., Manickam M. Recent discovery and development of inhibitors targeting coronaviruses, Drug Discov. Today Off. 2020;25:668\u2013688. doi: 10.1016/j.drudis.2020.01.015.", "ArticleIdList": ["10.1016/j.drudis.2020.01.015", "PMC7102522", "32006468"]}, {"Citation": "Colson P., Rolain J.M., Lagier J.C., Brouqui P., Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020;55 doi: 10.1016/j.ijantimicag.2020.105932.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105932", "PMC7135139", "32145363"]}, {"Citation": "Sanders J.M., Monogue M.L., Jodlowski T.Z., Cutrell J.B. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA, J Am Med Assoc. 2020;323:1824\u20131836. doi: 10.1001/jama.2020.6019.", "ArticleIdList": ["10.1001/jama.2020.6019", "32282022"]}, {"Citation": "Nojomi M., Yassin Z., Keyvani H., Makiani M.J., Roham M., Laali A., Dehghan N., Navaei M., Ranjbar M. Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial. BMC Infect Dis. 2020;20:1\u201310.", "ArticleIdList": ["PMC7734453", "33317461"]}, {"Citation": "Hung I.F.N., Lung K.C., Tso E.Y.K., Liu R., Chung T.W.H., Chu M.Y., Ng Y.Y., Lo J., Chan J., Tam A.R., Shum H.P., Chan V., Wu A.K.L., Sin K.M., Leung W.S., Law W.L., Lung D.C., Sin S., Yeung P., Yip C.C.Y., Zhang R.R., Fung A.Y.F., Yan E.Y.W., Leung K.H., Ip J.D., Chu A.W.H., Chan W.M., Ng A.C.K., Lee R., Fung K., Yeung A., Wu T.C., Chan J.W.M., Yan W.W., Chan W.M., Chan J.F.W., Lie A.K.W., Tsang O.T.Y., Cheng V.C.C., Que T.L., Lau C.S., Chan K.H., To K.K.W., Yuen K.Y. Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020;395:1695\u20131704. doi: 10.1016/S0140-6736(20)31042-4.", "ArticleIdList": ["10.1016/S0140-6736(20)31042-4", "PMC7211500", "32401715"]}, {"Citation": "Li H., Wang Y.M., Xu J.Y., Cao B. Potential antiviral therapeutics for 2019 novel coronavirus. Zhonghua Jiehe He Huxi Zazhi. 2020;43:170\u2013172. doi: 10.3760/cma.j.issn.1001-0939.2020.03.004.", "ArticleIdList": ["10.3760/cma.j.issn.1001-0939.2020.03.004", "32164080"]}, {"Citation": "Adhikari B., Marasini B.P., Rayamajhee B., Bhattarai B.R., Lamichhane G., Khadayat K., Adhikari A., Khanal S., Parajuli N. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: a review. Phyther. Res. 2020:1\u201315. doi: 10.1002/ptr.6893.", "ArticleIdList": ["10.1002/ptr.6893", "PMC7675695", "33037698"]}, {"Citation": "Song Y.H., Kim D.W., Curtis-Long M.J., Yuk H.J., Wang Y., Zhuang N., Lee K.H., Jeon K.S., Park K.H. Papain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits. Biol Pharm Bull. 2014;37:1021\u20131028. doi: 10.1248/bpb.b14-00026.", "ArticleIdList": ["10.1248/bpb.b14-00026", "24882413"]}, {"Citation": "Kim D.W., Seo K.H., Curtis-Long M.J., Oh K.Y., Oh J.W., Cho J.K., Lee K.H., Park K.H. Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J Enzym Inhib Med Chem. 2014;29:59\u201363. doi: 10.3109/14756366.2012.753591.", "ArticleIdList": ["10.3109/14756366.2012.753591", "23323951"]}, {"Citation": "Park J.Y., Ko J.A., Kim D.W., Kim Y.M., Kwon H.J., Jeong H.J., Kim C.Y., Park K.H., Lee W.S., Ryu Y.B. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J Enzym Inhib Med Chem. 2016;31:23\u201330. doi: 10.3109/14756366.2014.1003215.", "ArticleIdList": ["10.3109/14756366.2014.1003215", "25683083"]}, {"Citation": "Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X., You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W., Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289\u2013293. doi: 10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q., Zhang L., Wang X. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215\u2013220.", "ArticleIdList": ["32225176"]}, {"Citation": "Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock 4 and AutoDockTools 4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30:2785\u20132791.", "ArticleIdList": ["PMC2760638", "19399780"]}, {"Citation": "Tian W., Chen C., Lei X., Zhao J., Liang J. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 2018;46:W363\u2013W367.", "ArticleIdList": ["PMC6031066", "29860391"]}, {"Citation": "Weiner S.J., Kollman P.A., Singh U.C., Case D.A., Ghio C., Alagona G., Profeta S., Weiner P. A new force field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc. 1984;106:765\u2013784."}, {"Citation": "Sen D., Debnath P., Debnath B., Bhaumik S., Debnath S. Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study. J Biomol Struct Dyn. 2020:1\u201322.", "ArticleIdList": ["PMC7544938", "32948116"]}, {"Citation": "Muchtaridi M., Dermawan D., Yusuf M. Molecular docking, 3D structure-based pharmacophore modeling, and ADME prediction of alpha mangostin and its derivatives against estrogen receptor alpha. J Young Pharm. 2018;10:252\u2013259."}, {"Citation": "Dassault Syst\u00e8mes BIOVIA . 2020. BIOVIA Discovery Studio."}, {"Citation": "Schr\u00f6dinger The PyMOL Molecular Graphics System. 2020;2.4"}, {"Citation": "Wolber G., Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model. 2005;45:160\u2013169.", "ArticleIdList": ["15667141"]}, {"Citation": "Dermawan D., Wathoni N., Muchtaridi M. Host-guest interactions of \u03b1\u2212Mangostin with (\u03b1,\u03b2,\u03b3)\u2212Cyclodextrins: semi-empirical quantum mechanical methods of PM6 and PM7. J Young Pharm. 2018;11:31\u201335. doi: 10.5530/jyp.2019.11.7.", "ArticleIdList": ["10.5530/jyp.2019.11.7"]}, {"Citation": "Qing X., Lee X.Y., De Raeymaeker J., Tame J.R., Zhang K.Y., De Maeyer M., Voet A.R. Pharmacophore modeling: advances, Limitations, and current utility in drug discovery. J Recept Ligand Channel Res. 2014;7:81\u201392."}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:1\u201313.", "ArticleIdList": ["PMC5335600", "28256516"]}, {"Citation": "Sander T., Freyss J., Von Korff M., Rufener C. DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model. 2015;55:460\u2013473.", "ArticleIdList": ["25558886"]}, {"Citation": "Kuriata A., Gierut A.M., Oleniecki T., Ciemny M.P., Kolinski A., Kurcinski M., Kmiecik S. CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures. Nucleic Acids Res. 2018;46:W338\u2013W343. doi: 10.1093/nar/gky356.", "ArticleIdList": ["10.1093/nar/gky356", "PMC6031000", "29762700"]}, {"Citation": "Stewart J.J.P., Cs\u00e1sz\u00e1r P., Pulay P. Fast semiempirical calculations. J Comput Chem. 1982;3:227\u2013228. doi: 10.1002/jcc.540030214.", "ArticleIdList": ["10.1002/jcc.540030214"]}, {"Citation": "Lipinski C.A. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1:337\u2013341.", "ArticleIdList": ["24981612"]}, {"Citation": "Ertl P., Rohde B., Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem. 2000;43:3714\u20133717.", "ArticleIdList": ["11020286"]}, {"Citation": "Yogasundaram H., Putko B.N., Tien J., Paterson D.I., Cujec B., Ringrose J., Oudit G.Y. Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment. Can J Cardiol. 2014;30:1706\u20131715.", "ArticleIdList": ["25475472"]}, {"Citation": "Shelley H., Babu R.J. Role of cyclodextrins in nanoparticle-based drug delivery systems. J Pharmacol Sci. 2018;107:1741\u20131753. doi: 10.1016/j.xphs.2018.03.021.", "ArticleIdList": ["10.1016/j.xphs.2018.03.021", "29625157"]}, {"Citation": "Haimhoffer \u00c1., Ruszny\u00e1k \u00c1., R\u00e9ti-Nagy K., Vasv\u00e1ri G., V\u00e1radi J., Vecserny\u00e9s M., B\u00e1cskay I., Feh\u00e9r P., Ujhelyi Z., Fenyvesi F. Cyclodextrins in drug delivery systems and their effects on biological barriers. Sci Pharm. 2019;87 doi: 10.3390/scipharm87040033.", "ArticleIdList": ["10.3390/scipharm87040033"]}, {"Citation": "Zhou P., Lou Yang X., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., Chen H.D., Chen J., Luo Y., Guo H., Di Jiang R., Liu M.Q., Chen Y., Shen X.R., Wang X., Zheng X.S., Zhao K., Chen Q.J., Deng F., Liu L.L., Yan B., Zhan F.X., Wang Y.Y., Xiao G.F., Shi Z.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u2013273. doi: 10.1038/s41586-020-2012-7.", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "Park Ji Young, et al. Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg Med Chem. 2012;20(19) doi: 10.1016/j.bmc.2012.07.038.", "ArticleIdList": ["10.1016/j.bmc.2012.07.038", "PMC7127169", "22884354"]}, {"Citation": "Park Ji Young, et al. Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biol Pharm Bull. 2012;35(11) doi: 10.1248/bpb.b12-00623.", "ArticleIdList": ["10.1248/bpb.b12-00623", "22971649"]}, {"Citation": "Park Ji Young, et al. Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorg Med Chem. 2013;21(13) doi: 10.1016/j.bmc.2013.04.026.", "ArticleIdList": ["10.1016/j.bmc.2013.04.026", "PMC7126891", "23647823"]}, {"Citation": "Ryu Young Bae, et al. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorg Med Chem. 2010;18(22) doi: 10.1016/j.bmc.2010.09.035.", "ArticleIdList": ["10.1016/j.bmc.2010.09.035", "PMC7126309", "20934345"]}, {"Citation": "Weng Jing Ru. Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63. Virus Res. 2019;273 doi: 10.1016/j.virusres.2019.197767.", "ArticleIdList": ["10.1016/j.virusres.2019.197767", "PMC7114872", "31560964"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "11"}, {"Year": "2021", "Month": "6", "Day": "17"}, {"Year": "2021", "Month": "6", "Day": "17"}, {"Year": "2021", "Month": "6", "Day": "30", "Hour": "6", "Minute": "44"}, {"Year": "2021", "Month": "7", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "1", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "6", "Day": "24"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34189252", "PMC8223117", "10.1016/j.imu.2021.100645", "S2352-9148(21)00134-9"]}}], "PubmedBookArticle": []}